The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
pharmaceutical industry updates on mergers recalls and new drug developments
Verdiva Bio has launched with a $410 million series A to develop weight loss drugs, including a weekly oral GLP-1 agonist. Roche's Chugai has partnered with Araris Biotech for a deal potentially worth over $780 million to create multi-payload antibody-drug conjugates. Meanwhile, Astellas has halted its early-stage lymphoma CAR-T therapy following a pipeline review, and Merck has acquired a vaccine plant in Ireland from WuXi Biologics for €500 million.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.